Shares of Valeant Pharmaceuticals International, Inc. (TSE:VRX – Get Free Report) (NYSE:VRX) were down 3.3% on Monday . The company traded as low as C$30.75 and last traded at C$30.80. Approximately 1,232,408 shares changed hands during trading, a decline of 11% from the average daily volume of 1,382,994 shares. The stock had previously closed at C$31.86.
Valeant Pharmaceuticals International Stock Down 3.3 %
The stock has a 50-day simple moving average of C$30.80.
About Valeant Pharmaceuticals International
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
Featured Stories
- Five stocks we like better than Valeant Pharmaceuticals International
- What Makes a Stock a Good Dividend Stock?
- Intel: Is Now the Time to Be Brave?Â
- Insider Trading – What You Need to Know
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Valeant Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.
